Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve

Autor: Evan M. Zahn, Lars Søndergaard, Felix Berger, John P. Cheatham, Andreas Eicken, Julie A. Vincent, Jonathan J. Rome, Jacqueline Kreutzer, Shabana Shahanavaz, Shicheng Weng, Lisa Bergersen, Thomas K. Jones, Doff B. McElhinney, David T. Balzer
Rok vydání: 2020
Předmět:
Adult
Balloon Valvuloplasty
Male
Cardiac Catheterization
medicine.medical_specialty
Time Factors
Adolescent
medicine.medical_treatment
030204 cardiovascular system & hematology
Ventricular Outflow Obstruction
Young Adult
03 medical and health sciences
0302 clinical medicine
Pulmonary Valve Replacement
medicine
Humans
Ventricular outflow tract
balloon dilation
In patient
030212 general & internal medicine
Child
Heart Valve Prosthesis Implantation
Pulmonary Valve
business.industry
pulmonary valvuloplasty
Stent
Recovery of Function
Middle Aged
Pulmonary Valve Insufficiency
Prosthesis Failure
Surgery
Treatment Outcome
medicine.anatomical_structure
Quartile
Heart Valve Prosthesis
Pulmonary valve
pulmonary valve replacement
Cohort
Balloon dilation
Female
Melody valve
Cardiology and Cardiovascular Medicine
business
Zdroj: Shahanavaz, S, Berger, F, Jones, T K, Kreutzer, J, Vincent, J A, Eicken, A, Bergersen, L, Rome, J J, Zahn, E, Søndergaard, L, Cheatham, J P, Weng, S, Balzer, D & McElhinney, D 2020, ' Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve ', JACC: Cardiovascular Interventions, vol. 13, no. 13, pp. 1529-1540 . https://doi.org/10.1016/j.jcin.2020.03.035
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2020.03.035
Popis: Objectives The aim of this analysis was to evaluate outcomes following transcatheter reintervention for degenerated transcatheter pulmonary valves (TPVs). Background TPV replacement (TPVR) with the Melody valve demonstrated sustained relief of right ventricular outflow tract (RVOT) obstruction and pulmonary regurgitation. Methods All patients who underwent TPVR with a Melody valve as part of 3 Medtronic-sponsored prospective multicenter studies were included. Transcatheter reinterventions included balloon dilation of the previously implanted Melody valve, placement of a bare-metal stent within the implanted TPV, or placement of a new TPV in the RVOT (TPV-in-TPV). Indications for reintervention, decisions to reintervene, and the method of reintervention were at physician discretion. All patients provided written informed consent to participate in the trials, and each trial was approved by local or central Institutional Review Boards or ethics committees at participating sites. Results A total of 309 patients who underwent TPVR were discharged from the implantation hospitalization with Melody valves in place. Transcatheter reintervention on the TPV was performed in 46 patients. The first transcatheter reintervention consisted of TPV-in-TPV in 28 patients (median 6.9 years [quartile 1 to quartile 3: 5.2 to 7.8 years] after TPVR), simple balloon dilation of the implanted Melody valve in 17 (median 4.9 years [quartile 1 to quartile 3: 4.0 to 6.0 years] after TPVR), and bare-metal stent placement alone in 1 (4.4 years after TPVR). There were no major procedural complications. Overall, 4-year freedom from explant and from any later RVOT reintervention after the first reintervention were 83% and 60%, respectively. Freedom from repeat RVOT reintervention was longer in patients undergoing TPV-in-TPV than balloon dilation (71% vs. 46% at 4 years; p = 0.027). Conclusions TPV-in-TPV can be an effective and durable treatment for Melody valve dysfunction. Although balloon dilation of the Melody valve was also acutely effective at reducing RVOT obstruction, the durability of this therapy was limited in this cohort compared with TPV-in-TPV.
Databáze: OpenAIRE